Oxidative Stress in Kainic Acid Neurotoxicity: Implications for the Pathogenesis of Neurotraumatic and Neurodegenerative Diseases

Oxidative Stress in Vertebrates and Invertebrates: Molecular Aspects of Cell Signaling

Volumn , Issue , 2011, Pages 51-62

  Farooqui, Akhlaq A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cholesterol metabolism alterations; Neurodegenerative disease; Oxidative stress, KA neurotoxicity

Indexed keywords

EID: 84886842749     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118148143.ch4     Document Type: Chapter

References (71)

1. Ikeda, M., Kihara, A., Igarashi, Y. Lipid asymmetry of the eukaryotic plasma membrane: functions and related enzymes. Biol Pharmaceut Bull 2006; 29: 1542-1546.
2. Yamaji-Hasegawa, A., Tsujimoto, M. Asymmetric distribution of phospholipids in biomembranes. Biol Pharmaceut Bull 2006; 29: 1547-1553.
3. Zajchowski, L.D., Robbins, S.M. Lipid rafts and little caves-Compartmentalized signalling in membrane microdomains. Eur J Biochem 2002; 269: 737-752.
4. Lucero, H.A., Robbins, P.W. Lipid rafts-protein association and the regulation of protein activity. Arch Biochem Biophys 2004; 426: 208-224.
5. Farooqui, A.A. Hot Topics in Neural Membrane Lipidology. New York: Springer, 2009.
6. Farooqui, A.A. Lipid Mediators and their metabolites in the Brain. New York: Springer 2011.
7. Farooqui, A.A., Ong, W.Y., Horrocks, L.A. Neurochemical Aspects of Excitotoxicity. New York: Springer, 2008, pp. 1-290.
8. Coyle, J.T. Neurotoxic action of kainic acid. J Neurochem 1983; 41: 1-11.
9. Lerma, J. Kainate reveals its targets. Neuron 1997; 19: 1155-1158.
10. Meldrum, B., Garthwaite, J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990; 11: 379-387.
11. Al Noori, S., Swann, J.W., A role for sodium and chloride in kainic acid-induced beading of inhibitory interneuron dendrites. Neuroscience 2000; 101: 337-348.
12. Ong, W.Y., Ren, M.Q., Makjanic, J., Lim, T.M., Watt, F. A nuclear microscopic study of elemental changes in the rat hippocampus after kainate-induced neuronal injury. J Neurochem 1999; 72: 1574-1579.
13. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 628-634.
14. Farooqui, A.A., Ong, W.Y., Lu, X.R., Halliwell, B., Horrocks, L.A. Neurochemical consequences of kainateinduced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A2 inhibitors. Brain Res Rev 2001; 38: 61-78.
15. Zhu, W., Zheng, H., Shao, X., Wang, W., Yao, Q., Li, Z. Excitotoxicity of TNFalpha derived from KA activated microglia on hippocampal neurons in vitro and in vivo. J Neurochem 2010; 114: 386-396.
16. Sanfeliu, C., Hunt, A., Patel, A.J. Exposure to N-methyl- D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res 1990; 526: 241-248.
17. Kim, D.K., Rordorf, G., Nemenoff, R.A., Koroshetz,W.J., Bonventre, J.V. Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures. Biochem J 1995; 310: 83-90.
18. Farooqui, A.A., Rammohan, K.W., Horrocks, L.A. Isolation, characterization, and regulation of diacylglycerol lipases from the bovine brain. Ann NY Acad Sci 1989; 559: 25-36.
19. Sandhya, T.L., Ong, W.Y., Horrocks, L.A., Farooqui, A. A. A light and electron microcopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesion. Brain Res 1998; 788: 223-231.
20. Ong, W.Y., Goh, E.W.S., Lu, X.R., Farooqui, A.A., Patel, S.C., Halliwell, B. Increase in cholesterol and cholesterol oxidation products, and role of cholesterol oxidation products in kainate-induced neuronal injury. Brain Pathol 2003; 13: 250-262.
21. Jarvela , J.T.,Ruohonen, S.,Kukko-Lukjanov,T.K.,Plysjuk, A., Lopez-Picon, F.R., Holopainen, I.E. Kainic acidinduced neurodegeneration and activation of inflammatory processes in organotypic hippocampal slice cultures: treatment with cyclooxygenase-2 inhibitor does not prevent neuronal death. Neuropharmacology 2010; Epub ahead of print.
22. Farooqui, A.A., Ong, W.Y., Horrocks, L.A. Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4: 85-96.
23. Fam, S.S., Morrow, J.D. The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 2003; 10: 1723-1740.
24. Comporti, M., Signorini, C., Arezzini, B., Vecchio, D., Monaco, B., Gardi, C. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med 2008; 44: 247-256.
25. Farooqui, A.A., Ong, W.Y., Horrocks, L.A., Chen, P., Farooqui, T. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 2007; 56: 443-471.
26. Pryor, W., Squadrite, G. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Ann J Physiol 1995; 268: 699-722.
27. Bolaños, J.P., Almeida, A., Stewart, V., Peuchen, S., Land, J. M., Clark, J.B., Heales, S.J.Nitric oxide-mediatedmitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 1997; 68: 2227- 2240.
28. Guan, X.L., He, X., Ong, W.Y., Yeo, W.K., Shui, G.H., Wenk,M.R.,Non-targeted profiling of lipids during kainateinduced neuronal injury. FASEB J 2006; 20: 1152-1161.
29. He, X., Guan, X.L., Ong, W.Y., Farooqui, A.A., Wenk, M.R. Expression, activity, and role of serine palmitoyltransferase in the rat hippocampus after kainate injury. J Neurosci Res 2007; 85: 423-432.
30. Yu, Z., Cheng, G., Wen, X., Wu, G.D., Lee, W.T., Pleasure D. Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappaBdependent mechanism. Neurobiol Dis 2002; 11: 199-213.
31. Lee, D.H., Jeon, B.T., Jeong, E.A., Kim, J.S., Cho, Y.W., Kim, H.J., Kang, S.S., Cho, G.J., Choi, W.S., Roh, G.S. (2010). Altered expression of sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 in mouse hippocampus after kainic acid treatment. Biochem Biophys Res Commun 2010; 393: 476-480.
32. Dietschy, J.M., Turley, S.D. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001; 12: 105-112.
33. Pfrieger, F.W. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? BioEssays 2003; 325: 72-78.
34. Gylys, K.H., Fein, J.A., Yang, F.,Miller, C.A., Cole, G.M. Increased cholesterol in A -positive nerve terminals from Alzheimer's disease cortex. Neurobiol Aging 2007; 28: 8-17.
35. Ma, M.T., Zhang, J., Farooqui, A.A., Chen, P., Ong, W.Y. Effects of cholesterol oxidation products on exocytosis. Neurosci Lett 2010; 476: 36-41.
36. Park, D.S., Obeidat, A., Giovanni, A., Greene, L.A. Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiol Aging 2000; 21: 771-781.
37. Zhang, J., Ahea, Y., el-Etr, M., Baulieu, E.E. Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. Biochem J 1997; 322: 175-184.
38. Koudinov, A.R., Koudinova, N.V., (2003). Amyloid beta protein restores hippocampal long term potentiation: a central role for cholesterol? Neurobiol Lipids 2003; 1: 45-56.
39. Millanvoye-Van Brussel, E., Topal, G., Brunet, A., Do Phaw, T., Deckert, V., Rendu, F., David-Dufilho, M. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. Biochem J 2004; 380: 533-539.
40. Farooqui, A.A. Lipid Mediators in the Brain: the Good, the Bad, and the Ugly. New York: Springer, 2011.
41. Farooqui, A.A., Horrocks, L.A., Farooqui, T. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide. J Neurosci Res 2007; 85: 1834-1850.
42. Lizard, G., Miguet, C., Bessède, G., Monier, S., Gueldry, S., Neel, D., Gambert, P. Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occurring during 7-ketocholesterol-induced apoptosis. Free Radic Biol Med 2000; 28: 743-753.
43. Nelson, T.J., Alkon, D.L. Oxidation of cholesterol by amyloid precursor protein and ß-amyloid peptide. J Biol Chem 2005; 280: 7377-7387.
44. He, X., Jenner, M., Ong, W.Y., Farooqui, A.A., Patel, S. C. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J Neuropathol Exp Neurol 2006; 65: 652-663.
45. Bollinger, C.R., Teichgraber, V., Gulbins, E. Ceramideenriched membrane domains. Biochim Biophys Acta 2005; 1746: 284-294.
46. Farooqui, A.A., Horrocks, L.A., Glycerophospholipids in the Brain: Phospholipases A2 in Neurological Disorders. New York: Springer, 2007, pp. 1-394.
47. Dumitru, C.A., Zhang, Y., Li, X., Gulbin, E. Ceramide: a novel player in reactive oxygen species-induced signaling? Antioxid Redox Signal 2007; 9: 1535-1540.
48. Farooqui, A.A., Ong, W.Y., Horrocks, L.A. Plasmalogens, docosahexaenoic acid, and neurological disorders. In: Roels, F., Baes, M., de Bies, S., editors. Peroxisomal Disorders and Regulation of Genes. London: Kluwer Academic/ Plenum, 2003, p. 335-354.
49. Latorre, E., Aragone s,M.D., Fernandez, I., Catalan, R.E., Platelet-activating factor modulates brain sphingomyelin metabolism. Eur J Biochem 1999; 262: 308-314.
50. Farooqui, A.A., Horrocks, L.A. Excitotoxicity and neurological disorders: involvement of membrane phospholipids. Int Rev Neurobiol 1994; 36: 267-323.
51. Bloss, E.B., Hunter, R.G. Hippocampal kainate receptors. Vitam Horm 2010; 82: 167-184.
52. Farooqui, A.A. Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases. New York: Springer, 2010.
53. Sun, G.Y., Horrocks, L.A., Farooqui, A.A. The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neurochem 2007; 103: 1-16.
54. Farooqui, T., Farooqui, A.A. Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 2009; 130: 203-215.
55. Bi, H., Sze, C.I. N-Methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J Neurol Sci 2002; 200: 11-18.
56. Kawahara, Y., Ito, K., Sun, H., Ito, M., Kanazawa, I., Kwak, S. GluR4c, an alternative splicing isoform of GluR4, is abundantly expressed in the adult human brain. Brain Res Mol Brain Res 2004; 127: 150-155.
57. Kawahara, Y., Sun, H., Ito, K., Hideyama, T., Aoki, M., Sobue, G., Tsuji, S., Kwak, S. Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci Res 2006; 54: 11-14.
58. Rothstein, J.D., Van Kammen, M., Levey, A.I., Martin, L. J., Kuncl, R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
59. Zeron, M.M., Fernandes, H.B., Krebs, C., Shehadeh, J., Wellington, C.L., Leavitt, B.R., Baimbridge, K.G., Hayden, M.R., Raymond, L.A. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease. Mol Cell Neurosci 2004; 25: 469- 479.
60. McKrachen, E., Graham, D.I., Nilsen, M., Stewart, J., Nicoll, J.A., Horsburgh, K. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol 2001; 11: 414-421.
61. Musiek, E.S., Milne, G.L., Morrow, J.D. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 2005; 40: 987-994.
62. Patel, M., Liang, L.D., Roberts, L.J., 2nd. Enhanced hippocampal F2-isoprostane formation following kainateinduced seizures. J Neurochem 2001; 79: 1065-1069.
63. Adibhatla, R.M., Hatcher, J.F. Protection by D609 through cell-cycle regulation after stroke. Mol Neurobiol 2010; 41: 206-217.
64. Han, X., Holtzman, D., McKeel, D.W. jr., Kelley, J., Morris, J.C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 2002; 82: 809-818.
65. Yu, Z.F., Nikolova-Karakashian, M., Zhou, D.H., Cheng, G.J., Schuchman, E.H., Mattson, M.P. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 2000; 15: 85-97.
66. Farooqui, A.A., Horrocks, L.A. Glutamate and cytokinemediated alterations of phospholipids in head injury and spinal cord trauma. In: Banik, N., Ray, S.K., Lajtha, A. editors, Brain and Spinal Cord Trauma. Handbook of Neurochemistry, Vol. 24, 3rd ed. New York: Springer, 2009, pp. 71-89.
67. Marchesini, N., Hannun, Y.A. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 2004; 82: 27-44.
68. Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., Troncoso, J.C., Mattson, M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 2004; 17: 2070-2075.
69. Holdenrieder, S., Lutjohann, D., Geiger, S., von Bergmann, K., Stieber, P., Hamann, G.F. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? Neurosci Lett 2004; 368: 201-204.
70. Lutjohann, D., von Bergmann, K. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Pharmacopsychiatry 2003; 36 Suppl. 2: S102-S106.
71. Yao, Z.X., Brown, R.C., Teper, G., Greeson, J., Papadopoulos V. 22R-Hydroxycholesterol protects neuronal cells from beta-amyloid-induced cytotoxicity by binding to beta-amyloid peptide. J Neurochem 2002; 83: 1110-1119.